Literature DB >> 25959607

Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia.

D Tsakogiannis1, P Gortsilas1, Z Kyriakopoulou1, I G A Ruether1, T G Dimitriou1, G Orfanoudakis2, P Markoulatos1.   

Abstract

Integration of HPV16 DNA into the host chromosome usually disrupts the E1 and/or E2 genes. The present study investigated the disruption of E1, E2 genes in a total of eighty four HPV16-positive precancerous and cervical cancer specimens derived from Greek women (seventeen paraffin-embedded cervical biopsies and sixty seven Thin Prep samples). Complete E2 and E1 genes were amplified using three and nine overlapping primer sets respectively, in order to define the sites of disruption. Extensive mapping analysis revealed that disruption/deletion events within E2 gene occurred in high grade and cervical cancer samples (x(2) test, P < 0.01), while no evidence of E2 gene disruption was documented among low grade cervical intraepithelial neoplasias. In addition, disruptions within the E1 gene occur both in high and low grade cervical intraepithelial neoplasia. This leads to the assumption that in low grade cervical intraepithelial neoplasias only E1 gene disruption was involved (Fisher's exact test, P < 0.05), while in high grade malignancies and cervical cancer cases deletions in both E1 and E2 genes occurred. Furthermore, the most prevalent site of disruption of E1 gene was located between nucleotides 1059 and 1323, while the most prevalent deleted region of the E2 gene was located between nucleotides 3172 and 3649 (E2 hinge region). Therefore, it is proposed that each population has its own profile of frequencies and sites of disruptions and extensive mapping analysis of E1 and E2 genes is mandatory in order to determine suitable markers for HPV16 DNA integration analysis in distinct populations.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  E1 disruption; E2 disruption; HPV DNA physical state; HPV16; HPV16 integration

Mesh:

Substances:

Year:  2015        PMID: 25959607     DOI: 10.1002/jmv.24256

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues.

Authors:  Corina N A M van den Heuvel; Diede L Loopik; Renée M F Ebisch; Duaa Elmelik; Karolina M Andralojc; Martijn Huynen; Johan Bulten; Ruud L M Bekkers; Leon F A G Massuger; Willem J G Melchers; Albert G Siebers; William P J Leenders
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

2.  Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.

Authors:  Phetploy Rungkamoltip; Sasithon Temisak; Kitiya Piboonprai; Deanpen Japrung; Pattanapong Thangsunan; Saranya Chanpanitkitchot; Woraphot Chaowawanit; Nutthaporn Chandeying; Siriwan Tangjitgamol; Tawin Iempridee
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-13

3.  HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability.

Authors:  Jun-Wei Zhao; Fang Fang; Yi Guo; Tai-Lin Zhu; Yun-Yun Yu; Fan-Fei Kong; Ling-Fei Han; Dong-Sheng Chen; Fang Li
Journal:  J Exp Clin Cancer Res       Date:  2016-11-25

4.  Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology.

Authors:  María Del R González-Losa; Marylin Puerto-Solis; Juan Tenorio Ruiz; Ariel I Rosado-López; Oscar Hau-Aviles; Guadalupe Ayora-Talavera; Isidro Cisneros-Cutz; Laura Conde-Ferráez
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-31       Impact factor: 2.743

5.  HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma.

Authors:  Gabriella Lillsunde Larsson; Malin Kaliff; Bengt Sorbe; Gisela Helenius; Mats G Karlsson
Journal:  Papillomavirus Res       Date:  2018-11-02

6.  Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population.

Authors:  Yueting Yao; Zhiling Yan; Shuying Dai; Chuanyin Li; Longyu Yang; Shuyuan Liu; Xinwen Zhang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2019-06-24       Impact factor: 3.738

7.  Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples.

Authors:  Karoline Andersen; Kasper Holm; Mette Tranberg; Cecilie Lebech Pedersen; Sara Bønløkke; Torben Steiniche; Berit Andersen; Magnus Stougaard
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

8.  Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.

Authors:  Nicole V Anayannis; Nicolas F Schlecht; Miriam Ben-Dayan; Richard V Smith; Thomas J Belbin; Thomas J Ow; Duk M Blakaj; Robert D Burk; Sarah M Leonard; Ciaran B Woodman; Joanna L Parish; Michael B Prystowsky
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

9.  HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.

Authors:  Sérgio Menezes Amaro-Filho; Cláudia Bessa Pereira Chaves; Shayany Pinto Felix; Diogo Lisbôa Basto; Liz Maria de Almeida; Miguel Angelo Martins Moreira
Journal:  Papillomavirus Res       Date:  2018-04-09

10.  HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.

Authors:  Saurabh Baheti; Xiaojia Tang; Daniel R O'Brien; Nicholas Chia; Lewis R Roberts; Heidi Nelson; Judy C Boughey; Liewei Wang; Matthew P Goetz; Jean-Pierre A Kocher; Krishna R Kalari
Journal:  BMC Bioinformatics       Date:  2018-07-17       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.